Research ArticleClinical Studies
Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors
HARUKA KANAOKA, MASAYUKI NAGAHASHI, YUSA ATAKE, AKIRA HATTORI, AYAKO BUN, REIKO FUKUI, HIROMI OZAWA, YUKIE FUJIMOTO, TOMOKO HIGUCHI, KEIKO NATORI, MICHIKO IMAMURA, KEIKO MURASE, YUICHI TAKATSUKA and YASUO MIYOSHI
Anticancer Research October 2022, 42 (10) 4867-4878; DOI: https://doi.org/10.21873/anticanres.15992
HARUKA KANAOKA
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya, Japan
MASAYUKI NAGAHASHI
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya, Japan
YUSA ATAKE
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya, Japan
AKIRA HATTORI
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya, Japan
AYAKO BUN
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya, Japan
REIKO FUKUI
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya, Japan
HIROMI OZAWA
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya, Japan
YUKIE FUJIMOTO
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya, Japan
TOMOKO HIGUCHI
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya, Japan
KEIKO NATORI
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya, Japan
MICHIKO IMAMURA
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya, Japan
KEIKO MURASE
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya, Japan
YUICHI TAKATSUKA
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya, Japan
YASUO MIYOSHI
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya, Japan
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors
HARUKA KANAOKA, MASAYUKI NAGAHASHI, YUSA ATAKE, AKIRA HATTORI, AYAKO BUN, REIKO FUKUI, HIROMI OZAWA, YUKIE FUJIMOTO, TOMOKO HIGUCHI, KEIKO NATORI, MICHIKO IMAMURA, KEIKO MURASE, YUICHI TAKATSUKA, YASUO MIYOSHI
Anticancer Research Oct 2022, 42 (10) 4867-4878; DOI: 10.21873/anticanres.15992
Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors
HARUKA KANAOKA, MASAYUKI NAGAHASHI, YUSA ATAKE, AKIRA HATTORI, AYAKO BUN, REIKO FUKUI, HIROMI OZAWA, YUKIE FUJIMOTO, TOMOKO HIGUCHI, KEIKO NATORI, MICHIKO IMAMURA, KEIKO MURASE, YUICHI TAKATSUKA, YASUO MIYOSHI
Anticancer Research Oct 2022, 42 (10) 4867-4878; DOI: 10.21873/anticanres.15992
Jump to section
Related Articles
- No related articles found.